Induction of immunological memory in baboons primed with DNA vaccine as neonates

Vaccine

Volumn 19, Issue 15-16, 2001, Pages 1960-1967

  Bot, Adrian ^a   Shearer, Michael ^b   Bot, Simona ^a   Avriette, Mary ^a   Garcia Sastre, Adolfo ^c   White, Gary ^b   Woods, Catherine ^a   Kennedy, Ronald ^b   Bona, Constantin ^c  

^a Alliance Pharmaceutical Corporation   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

DNA vaccination; Influenza virus; Neonates; Primates

Indexed keywords

DNA VACCINE; HEMAGGLUTINATION INHIBITING ANTIBODY; INFLUENZA VACCINE; VIRUS ANTIBODY;

ADOLESCENT; ANTIBODY RESPONSE; ARTICLE; BABOON; CELLULAR IMMUNITY; CONTROLLED STUDY; DOSE RESPONSE; HUMORAL IMMUNITY; IMMUNOGENICITY; IMMUNOLOGICAL MEMORY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; VACCINATION;

AGE FACTORS; ANIMALS; ANIMALS, NEWBORN; ANTIBODIES, VIRAL; IMMUNITY, CELLULAR; IMMUNOLOGIC MEMORY; INFLUENZA A VIRUS; INFLUENZA VACCINES; KINETICS; PAPIO; VACCINES, DNA;

EID: 0035961463     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(00)00430-8     Document Type: Article

References (31)

1. Potential advantages and risks of nucleic acid vaccines for infant immunization
2. Neonatal immunoresponsiveness
3. DNA immunization of newborn mice with a plasmid expressing nucleoprotein of influenza virus
4. Immune response to neonatal genetic vaccination
5. Induction of cellular and humoral immunity against influenza virus by immunization of newborn mice with a plasmid bearing a hemagglutinin gene
6. DNA immunization circumvents deficient induction of T helper type 1 and cytotoxic T lymphocyte response in neonates and during early life
7. Induction of cytotoxic T cell responses in newborn mice by DNA immunization
8. Genetic immunization of seronegative one-day-old piglets against pseudorabies induces neutralizing antibodies but not protection and is ineffective in piglets from immune dams
9. Immune response of neonates elicited by somatic transgene vaccination with naked DNA
10. Studies on antibody responses following neonatal immunization with influenza hemagglutinin DNA or protein
11. CpG oligodeoxynucleotides can circumvent the Th2 polarization of neonatal responses to vaccines but may fail to fully redirect Th2 responses established by neonatal priming
12. Induction of neonatal tolerance by plasmid DNA vaccination of mice
13. Factors associated with the development of neonatal tolerance after the administration of a plasmid DNA vaccine
14. DNA immunization of neonates induces immunity despite the presence of maternal antibodies
15. Neonatal DNA immunization with a plasmid encoding an internal viral protein is effective in the presence of maternal antibodies and protects against subsequent challenge
16. Immunization of neonates with DNA encoding a bovine herpesvirus glycoprotein is effective in the presence of maternal antibodies
17. Influence of maternal antibodies on vaccine responses: Inhibition of antibody but not T cell responses allows successful early prime-boost strategies in mice
18. The influence of maternally derived antibody on the efficacy of further attenuated measles vaccine
19. Successful nucleic acid based immunization of newborn chimpanzees against hepatitis B virus
20. Safety and immunogenicity of intramuscular and intravaginal delivery of HIV-1 DNA constructs to infant chimpanzees
21. Induction of antibody response by DNA immunization of newborn baboons against influenza virus
22. Enhanced protection against influenza virus of mice immunized as newborns with a mixture of plasmids expressing hemagglutinin and nucleoprotein
23. Antiviral activity of antiserum specific for an influenza virus neuraminidase
24. Advanced laboratory techniques of influenza diagnosis
25. Immunization of non-human primates with DNA vaccines
26. Immunoglobulins
27. Comparative trial of influenza vaccines. II Adverse reactions in children and adults
28. DNA vaccination against virus infection and enhancement of antiviral immunity following consecutive immunization with DNA and viral vectors
29. Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunization